NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

IRRAS AB (publ) (ST: IRRAS)

 
IRRAS Technical Analysis
1
As on 3rd Nov 2023 IRRAS STOCK Price closed @ 0.16 and we RECOMMEND N/A for LONG-TERM with Stoploss of 0.00 & N/A for SHORT-TERM with Stoploss of 0.00 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

IRRASSTOCK Price

Open 0.16 Change Price %
High 0.16 1 Day N/A N/A
Low 0.16 1 Week 0.00 0.00
Close 0.16 1 Month 0.00 0.00
Volume 1452247 1 Year 0.00 0.00
52 Week High 0.00 | 52 Week Low 0.00
 
ST Sweden Most Active Stocks
TERRNT-B 0.38 %
TANGI 0.01 %
FING-B 0.07 %
SBB-B 6.21 %
OP 0.37 %
PROGEN 0.01 %
LUNE 21.97 6.65%
HDW-B 0.01 %
LIPI 0.08 %
XBRANE 0.17 %
 
ST Sweden Top Gainers Stocks
FEEL 0.09 12.50%
XPEC 2.52 7.69%
MAXF 50.20 6.81%
LUNE 21.97 6.65%
CARY 76.05 5.62%
LOYAL 7.36 5.44%
ZETA 8.15 4.76%
ZETA 8.15 4.76%
SECS 0.45 4.65%
ASPIRE 73.70 3.80%
 
ST Sweden Top Losers Stocks
ALLR 1.55 -26.54%
SARSYS 2.28 -8.06%
INVAJO 5.03 -7.20%
ECOWVE 4.30 -4.44%
CUR 2.17 -3.56%
CUR 2.17 -3.56%
PIEZO 31.90 -3.33%
GPXMED 2.49 -2.73%
ENDO 50.80 -2.68%
ENDO 50.80 -2.68%
 
 
IRRAS
Daily Charts
IRRAS
Intraday Charts
Whats New @
Bazaartrend
IRRAS
Free Analysis
 
IRRAS Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
 
IRRAS Forecast September 2024
4th UP Forecast0
3rd UP Forecast0
2nd UP Forecast0
1st UP Forecast0
1st DOWN Forecast0
2nd DOWN Forecast0
3rd DOWN Forecast0
4th DOWN Forecast0
 
IRRAS Weekly Forecast
4th UP Forecast0.00
3rd UP Forecast0.00
2nd UP Forecast0.00
1st UP Forecast0.00
1st DOWN Forecast0.00
2nd DOWN Forecast0.00
3rd DOWN Forecast0.00
4th DOWN Forecast0.00
 
IRRAS Forecast2024
4th UP Forecast0
3rd UP Forecast0
2nd UP Forecast0
1st UP Forecast0
1st DOWN Forecast0
2nd DOWN Forecast0
3rd DOWN Forecast0
4th DOWN Forecast0
 
 
IRRAS Other Details
Segment EQ
Market Capital 385086848.00
Sector Healthcare
Industry Medical Devices
Offical website >
 
IRRAS Address
IRRAS
 
IRRAS Latest News
 
Your Comments and Response on IRRAS AB (publ)
 
IRRAS Business Profile
IRRAS AB (publ), a medical device company, focuses on the delivery of medical solutions to enhance the lives of critically ill patients worldwide. It designs, develops, and commercializes neurocritical care products that transform patient outcomes and addresses complications associated with current treatment methodologies. The company offers IRRAflow, an irrigating intracranial drainage system that combines controlled drainage, automated irrigation, and integrated monitoring of intracranial pressure (ICP) for the treatment of patients suffering from hemorrhagic strokes and chronic subdural hematoma. It also provides Hummingbird ICP monitoring system comprising Hummingbird ICP Control Module (HICP200) and the related catheters, which include Hummingbird Quad ICP monitoring with drainage (H610), and Hummingbird Solo ICP monitoring (H110); and Hummingbird neuromonitoring products to manage patients suffering from conditions that cause an elevated intracranial pressure, including traumatic brain injury, subarachnoid hemorrhage, and strokes. The company markets and sells its products to hospitals through its direct sales force and a network of distribution partners. IRRAS AB (publ) was incorporated in 2011 and is headquartered in Stockholm, Sweden. Address: Vasagatan 16, Stockholm, Sweden, 111 20
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service